Sucrose for Procedural Pain Management in Infants
|
|
- Dwayne Peters
- 6 years ago
- Views:
Transcription
1 Sucrose for Procedural Pain Management in Infants abstract The use of oral sucrose has been the most extensively studied pain intervention in newborn care to date. More than 150 published studies relating to sweet-taste-induced calming and analgesia in human infants have been identified, of which 100 (65%) include sucrose. With only a few exceptions, sucrose, glucose, or other sweet solutions reduced pain responses during commonly performed painful procedures in diverse populations of infants up to 12 months of age. Sucrose has been widely recommended for routine use during painful procedures in newborn and young infants, yet these recommendations have not been translated into consistent use in clinical practice. One reason may be related to important knowledge and research gaps concerning analgesic effects of sucrose. Notably, the mechanism of sweet-taste-induced analgesia is still not precisely understood, which has implications for using research evidence in practice. The aim of this article is to review what is known about the mechanisms of sucrose-induced analgesia; highlight existing evidence, knowledge gaps, and current controversies; and provide directions for future research and practice. Pediatrics 2012;130: AUTHORS: Denise Harrison, RN, RM, PhD, a,b,c,d Simon Beggs, PhD, e,f and Bonnie Stevens, RN, PhD g,h,i a Centre for Practice Changing Research, Children s Hospital of Eastern Ontario, Ottawa, Canada; b School of Nursing, Faculty of Health Sciences, University of Ottawa, Ottawa, Canada; c Murdoch Childrens Research Institute, Parkville, Australia; d The University of Melbourne Faculty of Medicine, Dentistry and Health Sciences, Melbourne, Australia; e Program in Neurosciences & Mental Health, Hospital for Sick Children, Toronto, Canada; f Faculty of Dentistry, University of Toronto, Toronto, Canada; g Lawrence S. Bloomberg Faculty of Nursing and Faculty of Medicine, and h University of Toronto Centre for the Study of Pain, University of Toronto, Toronto, Canada; and i Senior Scientist Research Institute, The Hospital for Sick Children Toronto, Canada KEY WORDS pain, infant, neonate, sucrose, analgesia ABBREVIATIONS CNS central nervous system NNS nonnutritive sucking PIPP Premature Infant Pain Profile RCT randomized controlled trial doi: /peds Accepted for publication Jun 21, 2012 Address correspondence to Denise Harrison, RN, RM, PhD, 3rd Floor RGN Building, School of Nursing, Faculty of Health Sciences, 401 Smyth Rd, Ottawa, Ontario, Canada K1H 8L1. denise. harrison@uottawa.ca PEDIATRICS (ISSN Numbers: Print, ; Online, ). Copyright 2012 by the American Academy of Pediatrics FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose. (Continued on last page) 918 HARRISON et al
2 REVIEW ARTICLE The use of oral sucrose has been the most extensively studied pain intervention in newborn care to date. More than 150 published studies relating to sweet-taste-induced calming and analgesia in human infants have been identified, of which 100 (65%) include sucrose. With only a few exceptions, sucrose, glucose, or other sweet solutions reduced pain responses during commonly performed painful procedures in diverse populations of infants up to 12 months of age. 1 3 Sucrose has been widely recommended for routine use during painful procedures in newborn and young infants, 4 10 yet these recommendations have not been translated into consistent use in clinical practice One reason may be related to important knowledge and research gaps concerning analgesic effects of sucrose. Notably, the mechanism of sweet-taste-induced analgesia is still not precisely understood, which has implications for using research evidence in practice. The aim of this article is to review what is known about the mechanisms of sucrose-induced analgesia; highlight existing evidence, knowledge gaps, and current controversies; and provide directions for future research and practice. HISTORICAL OVERVIEW Oral sucrose has been the most extensively studied procedure-related pain reduction strategy in neonatal care. 1,3 Although randomized controlled trials (RCTs) evaluating effects of sucrose in infants were not published until the late 1980s, there are historical references pertaining to the analgesic and calming benefits of sweet substances dating back to AD 632, when Prophet Mohammed recommended giving infants a well-chewed date. 14 Sugar solutions, often mixed with a combination of alcohol and cocaine or opium, were widely promoted in the late 1840s and early 1900s as an effective intervention to calm crying infants, alleviate colic pain, and reduce pain during procedures in young children. 15,16 Sugar mixed with wine or whisky was recommended for infant boys undergoing circumcision, 17 and in 1938, recommendations were made that suggested anesthesia for infants during surgery was often not required and that a sucker consisting of a sponge dipped in some sugar water will often suffice to calm a baby (p. 2021). 18 Language used to describe the effects of sucrose on infants from these early reports through to present-day studies varies from report to report. Terms such as calming and analgesic are frequently used interchangeably. Analgesia reduces behavioral and physiologic indicators of pain. Calming reduces observable behavioral indicators of pain and distress. The indicators for analgesia and calming are highly intertwined, making it difficult to discriminate between them. This is true as well for studies of sucrose using animal models. However, for the purposes of this article, the interpretation of these terms are as follows. Calm was defined by Blass and Ciaramitaro in 1994 as an alert yet quiet state; when infants cried less than 24 sec/min during the 10 min that preceded stimulation and were in an alert state as judged by eye opening and gross motor activity scores of approximately 0.5 or more (p. 40). 19 Calm is most commonly used to describe an alert and quiet, but not sedated state. Analgesia is defined by the International Association for the Study of Pain as the absence of pain in response to stimulation that would normally be painful 20 and pain is defined as An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Note: The inability to communicate verbally does not negate the possibility that an individual is experiencing pain and is in need of appropriate pain-relieving treatment. Pain is always subjective. 20 This use of the term analgesia, defined by the International Association for the Study of Pain, is particularly open to criticism when describing effects of most analgesic agents. Absence of pain, based on observational measures (behavioral indicators including facial expressions, crying, body movements) and composite measures (behavioral and physiologic indicators plus other indicators such as behavioral state, nurses perception of pain) is rarely achieved, yet the term is widely used in neonatal pain studies. This, highlights the subjective nature and selection of terms and the lack of clarity surrounding the term pain in infants among clinicians and researchers. In addition, the emotional component of pain in infants is not able to be interpreted. Despite many years of debate, 21 this lack of clarity of the definition and meaning of these terms still has an impact on the interpretation of infants responses to sucrose, especially because the mechanisms of sucrose are not fully understood in either animals or humans. ANIMAL MODEL STUDIES Investigations into the cellular and molecular mechanisms underlying the effects of sucrose in animal models are relatively sparse and hampered by varying methodologies. However, there is compelling evidence that an endogenous opioid-sweet taste relationship exists Calming and/or analgesic effects of sucrose that occur rapidly, last for several minutes, and can be blocked by systemic opioid receptor antagonists have been demonstrated in rats. 29,32 The mechanism of effects suggest an increase in serum and cerebrospinal fluid b-endorphin levels after orally ingested sucrose but not PEDIATRICS Volume 130, Number 5, November
3 intragastrically administered sucrose. 31 However, as in human infants, the literature is confounded in part by the difficulty in distinguishing between a calming and pain-relieving effect 33 (ie, separation of stress from nociceptive responses). There are few firm conclusions to be drawn from the animal literature on the mechanism of sucrose. Variability in age of animals, modality of testing, sucrose dose, and timing of administration makes direct comparison between studies difficult. Using c-fos as a surrogate of neural activity combined with behavioral testing, Anseloni and colleagues showed an age-dependent analgesic action of sucrose in rat pups. 32 Noxious activation of spinal c-fos, was significantly reduced with sucrose. Using reflex withdrawal thresholds to a noxious stimulus, Anseloni and colleagues demonstrated a postnatal window of efficacy of sucrose restricted to the first 2 or 3 weeks of life and also a clear rostrocaudal developmental gradient of this effect, with a delayed effect of sucrose on hind-paw responses compared with forepaw. Considerable postnatal development occurs in central nervous system (CNS) structures involved in both nociception and opiate-receptor-dependent modulation of nociceptive input, which accounts for these changing sucrose responses in animals. In another study, to elucidate the central pathways that mediate the effects of sucrose, Anseloni and colleagues again used c-fos activity in CNS neurons and behavioral reflex responses to probe into higher centers of the CNS. 37 Through the use of midcollicular lesions, they were able to isolate higher centers (eg, the forebrain), and show that sucrose persisted in attenuating the behavioral nociceptive responses in the rat pups, indicating that forebrain circuitry is not required for the activity of sucrose. Furthermore, using c-fos expression, they were able to map sucrose-induced activity in the CNS and showed that the solitary tract in the brainstem was activated. Because this is the primary relay in the ascending gustatory pathway, it is not surprising that there is activity after intraoral sucrose in animals. However, they also found evidence of activity in brainstem areas associated with descending pain modulation, the periaqueductal gray, and raphe nucleus. 37 The medullary raphe nucleus is a critical mediator of endogenous analgesia and modulates the analgesic actions of opioids. 38 Furthermore, the ingestion of hedonic foodstuffs (eg, sucrose) is associated with analgesia. 39 This effect has been proposed to be a consequence of suppressed reactions to distracting (ie, painful) stimuli mediated by the raphe nucleus. 39 In the adult rat model, the brainstem-spinal cord projections are an important source of nociceptive processing in the spinal cord. In the neonate, however, the descending inhibitory influences are not fully mature, 34,35 and descending inhibitory tone can only be detected after the third postnatal week in rats. 35,36 As such, the influence of oral sucrose on these structures and central nociceptive processing is unclear and requires further elucidation. Both the ascending gustatory and associated descending pathways are known to have an opioidreceptor-mediated modulated component, but where specifically within this pathway the antagonistic effects of opioid blockade on oral sucrose effects occurs is unclear. HUMAN MODEL STUDIES While the role of sucrose in reducing pain and stress in animal models was being studied, effects in human infants were also being evaluated. In 1989, Blass and colleagues first reported that sucrose was extraordinarily calming with effects persisting well beyond the initial sucrose dose. 40 Numerous subsequent studies reported the same findings Calming effects were clearly nonsedating, with infants remaining alert after sucrose administration. 19 In addition, effects were observed to be sweet-taste dependent, sucrose was more effective than glucose, and the least sweet sugar, lactose, was no more effective than water in reducing crying. To further test the endogenous opioid basis of sweettaste-induced calming, the response of sucrose in infants born to mothers on methadone was evaluated. 19 Because infants exposed to antenatal methadone have a poorly functioning endogenous opioid system, it was hypothesized that the sweet-tastemediated analgesic mechanism would not function in these infants. 19 Findings supported the hypothesis-, sucrose was ineffective in calming methadone exposed infants suffering from withdrawal symptoms, adding evidence to the association among sweet taste, an intact endogenous opioid system, and analgesia. Until recently, this was the only study examining effects of sucrose in infants with antenatal opioid exposure. From these studies demonstrating calming effects of sucrose on crying infants, the research questions turned to whether sucrose reduced pain if given before painful procedures. In the first published report of a placebocontrolled RCT of sucrose for procedural pain in newborn infants, sucrose significantly reduced crying during a heel lance and resulted in a more rapid return to a calm state compared to water. 48 Additionally, the combination of 24% sucrose solution and nonnutritive sucking (NNS) significantly reduced crying duration during circumcision, compared with no treatment or NNS with water. 48 The compelling evidence from these early studies demonstrating profound 920 HARRISON et al
4 REVIEW ARTICLE effects of oral sucrose in inducing and maintaining a calm yet awake state in newborn infants and reducing behavioral responses during painful procedures compared with water and less sweet solutions, set the stage for an abundance of subsequent studies, reviews, and systematic reviews. 1,3 A systematic review and meta-analysis of 44 RCTs showed that sucrose consistently reduced behavioral responses (cry duration, facial actions, and composite pain scores (consisting of behavioral and physiologic indicators) to tissue-damaging noxious procedures compared with placebo, no treatment, or less sweet solutions including breast milk. 3 An exception to these findings was when sucrose had minimal effects compared with water when given within hours of birth before intramuscular injection of vitamin K. 49 This finding concurred with an animal model study in which sucrose had no effect in reducing responses to thermal stimuli in newborn rats on the first day of life. 32 One explanation proposed for this more modest effect of sweet taste in the first 12 hours of birth may be due to high circulating serum b endorphins negating further increase in response to sweet taste. 50 Sucrose has also beenshown to be less effective when used for prolonged and/ or more intensely painful procedures. Although results of a meta-analysis of 4 studies conducted during eye examination showed sucrose significantly reduced Premature Infant Pain Profile (PIPP) scores, the effects were small and inconsistent between individual studies In addition, a 50% glucose solution was no more effective than water during circumcision, 55 and a single dose of sucrose failed to significantly reduce crying in older infants undergoing urethral catheterization 56 and venepuncture. 57 The reduced effectiveness of sweet solutions in these more invasive procedures of relatively long duration may be due to the shortlasting effects of a single dose given 2 minutes before the procedures. Effects may not be sustained over prolonged procedures, especially in infants beyond the newborn period. 1 Although the duration of sucrose for $5 minutes in healthy newborn infants has been demonstrated, 40,41,58,59 and in one study, a prolonged effect time up to 45 minutes in healthy newborns was reported, 59 a short effect time of only 1 minute was demonstrated in infants aged 5 to 7 weeks. 41 Based on these observations, administering sucrose in small aliquots throughout the duration of painful procedures of prolonged duration may ensure a more sustained analgesic effect. 2 Despite the strong evidential base of analgesic effects of sucrose in newborn and young infants for single painful procedures, 1 there remain knowledge gaps concerning the following: Opioid pathways involved in mechanism of effect, especially in the developing infant Effectiveness when administered with concomitant opioid analgesics Effectiveness when administered concurrently with other pain management strategies such as skinto-skin care Use, safety, and effectiveness when used repeatedly for extended periods in extremely low birth weight infants and sick infants requiring prolonged hospitalization Despite the extensive work conducted in animal laboratories from the 1980s onward, the mechanisms of analgesic effects of sweet solutions in human infants remain poorly understood. On the basis of animal studies, the key mechanism is believed to be sweettaste-induced b-endorphin release. 22,31 However, elevated serum levels of b-endorphin in response to oral sucrose has not been identified in human infants to date. 60 In addition, other central mechanisms of sucrose including dopamine and acetylcholine have been postulated. 61 Additional research is required to elucidate their role in pain reducing effects of sucrose. The limited understanding of sucrose mechanisms has also had an impact on the interpretation of nonbehavioral responses that are not attenuated by sucrose solutions. As highlighted in the systematic review of sucrose for analgesia in newborn infants undergoing painful procedures, 3 sucrose reduced behavioral responses and various composite pain measures during single episodes of short, sharp, painful procedures compared with no treatment, water, NNS, and small volumes of breast or formula milk. However, when examined in isolation, responses other than behavioral were less consistently attenuated by sucrose. Oxygen saturation during heel lance or venipuncture was not influenced by oral sucrose, and sucrose reduced heart rate changes from baseline in only half of the studies. 3 Similarly, cortical activity, as measured by EEG responses are inconsistent with behavioral responses. 62,63 No differences in EEG responses during heel lance between sucrose and water (measured,1 second after heel lance) 63 or glucose and water (averaged over 2 minutes after heel lance) 62 were demonstrated despite significant reduction in PIPP scores. In addition, hormonal responses as measured by salivary cortisol were not affected by sucrose administration during heel lance, circumcision, or all painful procedures during the first week of life in a NICU. 3 These studies highlight important questions about the mechanisms of sweet-tastemediated pain reducing responses, in particular, the inconsistency among behavioral, physiologic, hormonal, and cortical responses. In infants, the correlation between physiologic and PEDIATRICS Volume 130, Number 5, November
5 behavioral responses to pain is reported be only The dissociation, direction, and degree of responses is common among all types of pain indicators across all ages, illustrating the complexity of the responses to nociceptive stimuli and the subjective phenomenon of pain. 64 Given this complexity and weak correlation among various types of indicators, the ongoing, fundamental question remains whether there is an optimal indicator(s) of pain and what it might be in infants. The dissociation among behavioral, physiologic, and cortical responses illustrates that 1 pain outcome or 1 indicator of pain does not sufficiently capture the complete picture of pain. Another key unanswered question is to what extent the sweet-taste-mediated endogenous opioid effects occur in the context of exogenous opioid delivery. Whether sucrose reduces pain when given with concomitant opioid analgesics is an important question because the effectiveness of opioid analgesics alone in reducing pain in sick infants during acute painful procedures is questionable Sucrose given with exogenous opioid analgesics has only been evaluated in 2 studies. 70,71 Harrison et al 72 reported no statistically significant differences in behavioral responses during heel lance when infants were receiving opioid analgesics and sucrose compared with receiving sucrose alone. 70 However the number of observations when infants were receiving opioid analgesics (n = 79) may have been underpowered to detect a difference. Second, Marceau et al evaluated 24% sucrose during heel lance in newborn infants born to mothers on antenatal methadone, compared with nonmethadone exposed infants. 71 Eight of the 26 methadone-exposed infants were receiving morphine at the time of study for management of opioid withdrawal. No group differences in PIPP scores, heart rate, or oxygen saturation were reported. In fact, PIPP scores across all infants were all low, suggesting efficacy of sucrose even in the context of methadone exposure and withdrawal. The study had a number of limitations due to unblinding, and the small sample size of infants receiving morphine (n = 8 infants). Given the inconsistency of results with the only previous study evaluating sucrose for methadone exposed infants, 19 more research in this area is warranted. The previously established evidence regarding the ability of opioid antagonists to block analgesic effects of sweet solutions has also been called into question. Although in animal models, naloxone blocked analgesic effects of sucrose, 32 this same effect was not demonstrated in human newborn infants when naloxone was injected intravenously. 73 In fact, the opposite effect occurred; analgesic effects of naloxone were demonstrated. Such analgesic effects of opioid antagonists when given in low doses have been reported previously. 74 However, such conflicting results emphasize uncertainties as to the mechanism of sucrose analgesia, the opioid pathways responsible, as well as the differences between animal and human infant mechanisms precluding consistent application of bench to bedside findings. Although there is a plethora of published studies evaluating sucrose during single episodes of painful procedures, 1,3 knowledge gaps concerning the effectiveness and safety of multiple doses given during varying frequencies over the course of an infant s hospitalization remain. Prolonged use of sucrose for periods of.1 weeks duration, during repeated painful events has been reported in only 3 studies: 2 RCTs in preterm infants 75,76 and a longitudinal cohort study of infants hospitalized between 1 and 5 months, all of whom received sucrose during heel lance. 72 Both RCTs showed that sucrose was more effective than NNS alone or standard care, 75,76 and sucrose alone was more effective than NNS and topical anesthetic during repeated subcutaneous injections, although the combination of all 3 interventions had the largest effect. 76 Harrison et al 72 reported that behavioral indicators of pain remained persistently low with no increase in these parameters over the full course of infants hospitalization. In addition, changes in physiologic parameters in response to heel lance remained stable over the course of hospitalization. To date, these are the only studies examining prolonged use of sweet solutions for procedural pain management. Prolonged use of sucrose raises important questions related to effectiveness and safety, although there is a paucity of data relating to long-term outcomes. Johnston et al reported that preterm infants,31 weeks gestational age who received.10 doses of sucrose per 24 hours in the first week of life had poorer neurologic outcomes compared with infants who received fewer sucrose doses. 77 No differences in any safety outcomes after consistent use of sucrose for preterm infants over the first month of life were reported in another study. 75 These are the only studies that have reported on longer-term outcomes in infants after repeated sucrose use. PRACTICE AND RESEARCH IMPLICATIONS The complexities in interpreting such a diverse body of evidence relating to the role of sucrose in inducing calm and reducing pain responses, the prevailing deficiencies in understanding mechanisms involved in sucrose analgesia, and the dearth of evidence relating to extended and repeated use of sucrose in preterm and sick infants have 922 HARRISON et al
6 REVIEW ARTICLE resulted in debates and controversy over whether sucrose should be considered standard care. 1,61,63 The same argument applies to glucose, because many studies have shown that glucose, if sufficiently concentrated, also reduces pain in infants. 1,78,79 However, although basic science and clinical researchers and clinicians continue to address the knowledge and research gaps relating to analgesic effects and mechanisms of sucrose, we need to remain cognizant that untreated or poorly treated pain in fragile infants has well-documented short-term adverse consequences and potential longer-term negative effects. 4 Clinicians therefore have an ethical responsibility to minimize pain exposure; use sucrose appropriately for single painful procedures, along with other evidence-based strategies including NNS, kangaroo care, and breastfeeding when feasible; 80 and monitor use and effectiveness of these strategies over short- and long-term periods. Importantly, clinicians decisions must be based on the best evidence available and not swayed by single studies or pervasive myths. 81 Clinicians and researchers would, however, benefit from clear guidelines including recommended volumes and dosing regimens of sucrose. Although the authors of the Cochrane systematic review of sucrose analgesia in newborn infants could not establish an optimal sucrose dose, 3 only small volumes are required, such as 0.1 to 1 ml or 0.2 to 0.5 ml/kg. Researchers and clinicians should take into account tailoring doses based on context in which sucrose is to be used, including gestational and postnatal age of the infant, severity of illness, and the painful procedure being performed. Finally, a consensus on the definition of pain in infants may greatly assist pain researchers to use consistent terms and to use consistent outcome measurements in future studies. Remaining knowledge and research gaps concern the mechanism of the effects of sucrose, determination of the best indicator or combination of indicators for assessing pain in infants, effectiveness and safety for repeated use in extremely preterm infants and critically ill infants, effectiveness for infants exposed to antenatal methadone or receiving postnatal opioid analgesics, and best dosing regimes. CONCLUSIONS Prolific research concerning painreducing properties of sucrose has been conducted over the past 25 years, with indisputable evidence that small volumes significantly reduce behavioral responses and composite pain scores to painful procedures in newborn and young infants. Recommendations for practice include using small volumes of sucrose for painful procedures only; avoiding use for calming irritable infants who are not undergoing procedures; giving solutions in aliquots over the duration of the procedure for prolonged procedures; avoiding use of.10 doses per 24 hours, especially during the first week of life; and using other effective strategies during painful procedures when feasible. Future research needs to address remaining areas of uncertainty with the ultimate aim of ensuring that no infant suffers unnecessary pain during painful procedures. REFERENCES 1. Harrison D, Bueno M, Yamada J, Adams- Webber T, Stevens B. Analgesic effects of sweet-tasting solutions for infants: current state of equipoise. Pediatrics. 2010;126(5): Harrison D, Stevens B, Bueno M, et al. Efficacy of sweet solutions for analgesia in infants between 1 and 12 months of age: a systematic review. Arch Dis Child. 2010;95(6): Stevens B, Yamada J, Ohlsson A. Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database Syst Rev. 2010;(1):CD Batton DG, Barrington KJ, Wallman C; American Academy of Pediatrics Committee on Fetus and Newborn; American Academy of Pediatrics Section on Surgery; Canadian Paediatric Society Fetus and Newborn Committee. Prevention and management of pain in the neonate: an update. Pediatrics. 2006;118(5): Anand KJ; International Evidence-Based Group for Neonatal Pain. Consensus statement for the prevention and management of pain in the newborn. Arch Pediatr Adolesc Med. 2001;155(2): Harrison D; Australian College of Neonatal Nurses. Management of pain in sick hospitalised infants. Neonatal. Paediatr Child Health Nurs. 2006;9: Royal Australasian College of Physicians. Guideline Statement: Management of Procedure-related Pain in Neonates. Sydney, Australia: Paediatrics & Child Health Division, The Royal Australasian College of Physicians; Henderson-Smart D. Australian & New Zealand Neonatal Network, Evidence Uptake Using Networks - Newborn Pain project. Sydney, Australia: National Institute of Clinical Studies, National Health & Medical Research Council; Spence K, Henderson-Smart D, New K, Evans C, Whitelaw J, Woolnough R; Australian and New Zealand Neonatal Network. Evidenced-based clinical practice guideline for management of newborn pain. J Paediatr Child Health. 2010;46(4): Taddio A, Appleton M, Bortolussi R, et al. Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline. CMAJ. 2010;182(18):E843 E Carbajal R, Rousset A, Danan C, et al. Epidemiology and treatment of painful procedures in neonates in intensive care units. JAMA. 2008;300(1): Johnston C, Barrington KJ, Taddio A, Carbajal R, Filion F. Pain in Canadian NICUs: have we improved over the past 12 years? Clin J Pain. 2011;27(3): Stevens B, Abbott L, Yamada J, et al. Epidemiology and management of painful PEDIATRICS Volume 130, Number 5, November
7 procedures in hospitalized children across Canada. CMAJ. 2011;183:E403 E Islamic Voice. Relief of Pain: A Medical Discovery. Available at: com/april.2001/quran.htm. Accessed June 20, Holbrook S. The Golden Age of Quackery. New York, NY: Macmillan; Norberry J. Illicit Drugs, Their Use and the Law in Australia. Canberra, Australia: Parliament of Australia, Department of the Parliamentary Library; Blanton M. G. The behavior of the human infant during the first thirty days of life. Psychol Rev. 1917;24: Thorek M. Modern Surgical Technique. Vol 111. Montreal, Canada: Lippincott; Blass EM, Ciaramitaro V. A new look at some old mechanisms in human newborns: taste and tactile determinants of state, affect, and action. Monogr Soc Res Child Dev. 1994;59(1):I V, International Association for the Study of Pain. Taxonomy Available at: www. iasp-pain.org/content/navigationmenu/ GeneralResourceLinks/PainDefinitions/default. htm#analgesia. Accessed June 20, Anand KJ, Craig KD. New perspectives on the definition of pain. Pain. 1996;67(1):3 6, discussion Bertiere MC, Sy TM, Baigts F, Mandenoff A, Apfelbaum M. Stress and sucrose hyperphagia: role of endogenous opiates. Pharmacol Biochem Behav. 1984;20(5): Rowland NE, Antelman SM. Stress-induced hyperphagia and obesity in rats: a possible model for understanding human obesity. Science. 1976;191(4224): Ren K, Blass EM, Zhou Q, Dubner R. Suckling and sucrose ingestion suppress persistent hyperalgesia and spinal Fos expression after forepaw inflammation in infant rats. Proc Natl Acad Sci USA. 1997;94(4): Blass EM, Shide DJ, Weller A. Stress-reducing effects of ingesting milk, sugars, and fats. A developmental perspective. Ann N Y Acad Sci. 1989;575: , discussion Shide DJ, Blass EM. Opioidlike effects of intraoral infusions of corn oil and polycose on stress reactions in 10-day-old rats. Behav Neurosci. 1989;103(6): Dum J, Gramsch C, Herz A. Activation of hypothalamic beta-endorphin pools by reward induced by highly palatable food. Pharmacol Biochem Behav. 1983;18(3): Czirr SA, Reid LD. Demonstrating morphine s potentiating effects on sucrose-intake. Brain Res Bull. 1986;17(5): Blass E, Fitzgerald E, Kehoe P. Interactions between sucrose, pain and isolation distress. Pharmacol Biochem Behav. 1987; 26(3): Lowy MT, Maickel RP, Yim GK. Naloxone reduction of stress-related feeding. Life Sci. 1980;26(24): Yamamoto T, Sako N, Maeda S. Effects of taste stimulation on beta-endorphin levels in rat cerebrospinal fluid and plasma. Physiol Behav. 2000;69(3): Anseloni VC, Weng HR, Terayama R, et al. Age-dependency of analgesia elicited by intraoral sucrose in acute and persistent pain models. Pain. 2002;97(1-2): Blass EM, Shide DJ. Some comparisons among the calming and pain-relieving effects of sucrose, glucose, fructose and lactose in infant rats. Chem Senses. 1994; 19(3): Fitzgerald M, Koltzenburg M. The functional development of descending inhibitory pathways in the dorsolateral funiculus of the newborn rat spinal cord. Brain Res. 1986;389(1 2): Hathway GJ, Koch S, Low L, Fitzgerald M. The changing balance of brainstem-spinal cord modulation of pain processing over the first weeks of rat postnatal life. J Physiol. 2009;587(pt 12): van Praag H, Frenk H. The development of stimulation-produced analgesia (SPA) in the rat. Brain Res Dev Brain Res. 1991;64: Anseloni VCZ, Ren K, Dubner R, Ennis M. A brainstem substrate for analgesia elicited by intraoral sucrose. Neuroscience. 2005; 133(1): Gebhart GF. Descending modulation of pain. Neurosci Biobehav Rev. 2004;27(8): Foo H, Mason P. Analgesia accompanying food consumption requires ingestion of hedonic foods. J Neurosci. 2009;29(41): Blass EM, Fillion TJ, Rochat P, Hoffmeyer LB, Rochat P, Metzger MA. Sensorimotor and motivational determinants of hand-mouth coordination in 1-3-day-old human infants. Dev Psychol. 1989;25(6): Barr RG, Quek VSH, Cousineau D, Oberlander TF, Brian JA, Young SN. Effects of intra-oral sucrose on crying, mouthing and hand-mouth contact in newborn and six-week-old infants. Dev Med Child Neurol. 1994;36(7): Barr RG, Pantel MS, Young SN, Wright JH, Hendricks LA, Gravel R. The response of crying newborns to sucrose: is it a sweetness effect? Physiol Behav. 1999;66(3): Barr RG, Young SN, Wright JH, Gravel R, Alkawaf R. Differential calming responses to sucrose taste in crying infants with and without colic. Pediatrics. 1999;103(5). Available at: Blass EM, Smith BA. Differential effects of sucrose, fructose, glucose, and lactose on crying in 1- to 3-day-old human infants: Qualitative and quantitative considerations. Dev Psychol. 1992;28(5): Graillon A, Barr RG, Young SN, Wright JH, Hendricks LA. Differential response to intraoral sucrose, quinine and corn oil in crying human newborns. Physiol Behav. 1997;62(2): Smith BA, Stevens K, Torgerson WS, Kim JH. Diminished reactivity of postmature human infants to sucrose compared with term infants. Dev Psychol. 1992;28(5): Smith BA, Blass E. Taste-mediated calming in premature, preterm, and full-term infants. Dev Psychol. 1996;32(6): Blass EM, Hoffmeyer LB. Sucrose as an analgesic for newborn infants. Pediatrics. 1991;87(2): Taddio A, Shah V, Hancock R, et al. Effectiveness of sucrose analgesia in newborns undergoing painful medical procedures. CMAJ. 2008;179(1): Facchinetti F, Bagnoli F, Bracci R, Genazzani AR. Plasma opioids in the first hours of life. Pediatr Res. 1982;16(2): Sun X, Lemyre B, Barrowman N, O Connor M. Pain management during eye examinations for retinopathy of prematurity in preterm infants: a systematic review. Acta Paediatr. 2010;99(3): Boyle EM, Freer Y, Khan-Orakzai Z, et al. Sucrose and non-nutritive sucking for the relief of pain in screening for retinopathy of prematurity: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2006; 91(3):F166 F Grabska J, Walden P, Lerer T, et al. Can oralsucrosereducethepainanddistress associated with screening for retinopathy of prematurity? J Perinatol. 2005;25 (1): Rush R, Rush S, Ighani F, Anderson B, Irwin M, Naqvi M. The effects of comfort care on the pain response in preterm infants undergoing screening for retinopathy of prematurity. Retina. 2005;25(1): Kass FC, Holman JR. Oral glucose solution for analgesia in infant circumcision. JFam Pract. 2001;50(9): Rogers AJ, Greenwald MH, Deguzman MA, Kelley ME, Simon HK. A randomized, controlled trial of sucrose analgesia in infants younger than 90 days of age who require bladder catheterization in the pediatric emergency department. Acad Emerg Med. 2006;13(6): HARRISON et al
8 REVIEW ARTICLE 57. Curtis SJ, Jou H, Ali S, Vandermeer B, Klassen T. A randomized controlled trial of sucrose and/or pacifier as analgesia for infants receiving venipuncture in a pediatric emergency department. BMC Pediatr. 2007;7: Smith BA, Fillion TJ, Blass EM. Orally mediated sources of calming in 1- to 3-day-old human infants. Dev Psychol. 1990;26(5): Taddio A, Shah V, Katz J. Reduced infant response to a routine care procedure after sucrose analgesia. Pediatrics. 2009;123(3): e425 e Taddio A, Shah V, Shah P, Katz J. Betaendorphin concentration after administration of sucrose in preterm infants. Arch Pediatr Adolesc Med. 2003;157(11): Holsti L, Grunau RE. Considerations for using sucrose to reduce procedural pain in preterm infants. Pediatrics. 2010;125(5): Norman E, Rosén I, Vanhatalo S, et al. Electroencephalographic response to procedural pain in healthy term newborn infants. Pediatr Res. 2008;64(4): Slater R, Cornelissen L, Fabrizi L, et al. Oral sucrose as an analgesic drug for procedural pain in newborn infants: a randomised controlled trial. Lancet. 2010;376(9748): doi: /s (10) 64. Barr RG. Reflections on measuring pain in infants: dissociation in responsive systems and honest signalling. Arch Dis Child Fetal Neonatal Ed. 1998;79(2):F152 F Carbajal R, Lenclen R, Jugie M, Paupe A, Barton BA, Anand KJS. Morphine does not provide adequate analgesia for acute procedural pain among preterm neonates. Pediatrics. 2005;115(6): Axelin A, Salanterä S, Kirjavainen J, Lehtonen L. Oral glucose and parental holding preferable to opioid in pain management in preterm infants. Clin J Pain. 2009;25(2): Simons SH, van Dijk M, van Lingen RA, et al. Routine morphine infusion in preterm newborns who received ventilatory support: a randomized controlled trial. JAMA. 2003;290(18): Anand KJ, Hall RW, Desai N, et al; NEOPAIN Trial Investigators Group. Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomised trial. Lancet. 2004;363 (9422): Cignacco E, Hamers JP, van Lingen RA, et al. Pain relief in ventilated preterms during endotracheal suctioning: a randomized controlled trial. Swiss Med Wkly. 2008;138 (43 44): Harrison D, Loughnan P, Manias E, Smith K, Johnston L. Effect of concomitant opioid analgesics and oral sucrose during heel lancing. Early Hum Dev. 2011;87(2): Marceau JR, Murray H, Nanan RKH. Efficacy of oral sucrose in infants of methadonemaintained mothers. Neonatology. 2010;97 (1): Harrison D, Loughnan P, Manias E, Gordon I, Johnston L. Repeated doses of sucrose in infants continue to reduce procedural pain during prolonged hospitalizations. Nurs Res. 2009;58(6): Gradin M, Schollin J. The role of endogenous opioids in mediating pain reduction by orally administered glucose among newborns. Pediatrics. 2005;115(4): Levine JD, Gordon NC. Method of administration determines the effect of naloxone on pain. Brain Res. 1986;365(2): Stevens B, Yamada J, Beyene J, et al. Consistent management of repeated procedural pain with sucrose in preterm neonates: Is it effective and safe for repeated use over time? Clin J Pain. 2005;21 (6): Mucignat V, Ducrocq S, Lebas F, Mochel F, Baudon JJ, Gold F. Analgesic effects of Emla cream and saccharose solution for subcutaneous injections in preterm newborns: a prospective study of 265 injections [in French]. Arch Pediatr. 2004;11(8): Johnston CC, Filion F, Snider L, et al. How much sucrose is too much sucrose? Pediatrics. 2007;119(1): Tsao JCI, Evans S, Meldrum M, Altman T, Zeltzer LK. A review of CAM for procedural pain in infancy: part I. Sucrose and nonnutritive sucking. Evid Based Complement Alternat Med. 2008;5(4): Kassab MI, Roydhouse JK, Fowler C, Foureur M. The effectiveness of glucose in reducing needle-related procedural pain in infants. J Pediatr Nurs. 2012;27(1): Harrison D, Yamada J, Stevens B. Strategies for the prevention and management of neonatal and infant pain. Curr Pain Headache Rep. 2010;14(2): Harrison D. Oral sucrose for pain management in infants: myths and misconceptions. J Neonatal Nurs. 2008;14(2): (Continued from first page) FUNDING: Dr Harrison is the holder of the Children s Hospital of Eastern Ontario (CHEO) Chair in Nursing Care of Children, Youth and Families at CHEO and the University of Ottawa. Dr Harrison was supported as a postdoctoral fellow by the Pain in Child Health Strategic Training Initiative (grant STP53885) and Canadian Institutes of Health Research Team Grant in Children s Pain (grants CTP and MOP-86605) (36,750/year) for 2 years from 2008 to Dr Harrison also received grants from CHEO Research Institute for an operating grant for a pilot study titled Be Sweet to Toddlers During Needles and 2 summer studentship grants in 2011 and 2012; a CHEO and Faculty of Health Sciences, University of Ottawa Partnership Grant titled Be Sweet to Sick Babies: Analgesic Effects of Oral Sucrose and Concomitant Opioid Analgesics: A Pilot Randomized Controlled Trial ; Canadian Institutes of Health Research (CIHR) Café Scientifique grant titled Be Sweet and Safe to Children and Youth During Pokes and Pains ; and a Nurses Board of Victoria, Australia, major research grant titled Be Sweet to Babies During Immunization. Dr Stevens is supported through the Signy Hildur Eaton Chair in Paediatric Nursing. Dr Stevens is the principal investigator on a CIHR operating grant titled Pain in Infants at Risk for Neurological Impairment: Phase 3 and a CIHR Team Grant in Children s Pain (grants CTP-79854, MOP and MOP ). PEDIATRICS Volume 130, Number 5, November
9 Sucrose for Procedural Pain Management in Infants Denise Harrison, Simon Beggs and Bonnie Stevens Pediatrics 2012;130;918 DOI: /peds originally published online October 8, 2012; Updated Information & Services References Subspecialty Collections Permissions & Licensing Reprints including high resolution figures, can be found at: This article cites 73 articles, 17 of which you can access for free at: This article, along with others on similar topics, appears in the following collection(s): Fetus/Newborn Infant orn_infant_sub Information about reproducing this article in parts (figures, tables) or in its entirety can be found online at: Information about ordering reprints can be found online: Pediatrics is the official journal of the American Academy of Pediatrics. A monthly publication, it has been published continuously since. Pediatrics is owned, published, and trademarked by the American Academy of Pediatrics, 141 Northwest Point Boulevard, Elk Grove Village, Illinois, Copyright 2012 by the American Academy of Pediatrics. All rights reserved. Print ISSN:.
10 Sucrose for Procedural Pain Management in Infants Denise Harrison, Simon Beggs and Bonnie Stevens Pediatrics 2012;130;918 DOI: /peds originally published online October 8, 2012; The online version of this article, along with updated information and services, is located on the World Wide Web at: Pediatrics is the official journal of the American Academy of Pediatrics. A monthly publication, it has been published continuously since. Pediatrics is owned, published, and trademarked by the American Academy of Pediatrics, 141 Northwest Point Boulevard, Elk Grove Village, Illinois, Copyright 2012 by the American Academy of Pediatrics. All rights reserved. Print ISSN:.
The Hierarchy of Evidence
The Hierarchy of Evidence The Hierarchy of evidence is based on summaries from the National Health and Medical Research Council (2009), the Oxford Centre for Evidence-based Medicine Levels of Evidence
More informationCLINICAL PROCEDURE MUHC
CLINICAL PROCEDURE MUHC Medication included No Medication included THIS IS NOT A MEDICAL ORDER Title: This procedure is attached to: Administration of sucrose 24% in pediatric population MUHC Patient Double
More informationBaby It Hurts. Deb Fraser, MN, RNC
Baby It Hurts Deb Fraser, MN, RNC Outline What is pain? Misconceptions about pain Problems with neonatal pain management Pain assessment Our view of pain? definitions Pain: An unpleasant sensory or emotional
More informationAll newborns experience pain from medical procedures
CMAJ JAMC RESEARCH Effectiveness of sucrose analgesia in newborns undergoing painful medical procedures Anna Taddio BScPhm PhD, Vibhuti Shah MD MSc, Rebecca Hancock MSc, Ryan W. Smith BASc MSc, Derek Stephens
More informationTHE EFFICACY OF ORAL GLUCOSE FOR RELIEVING PAIN FOLLOWING INTRAMUSCULAR INJECTION IN TERM NEONATES
THE EFFICACY OF ORAL GLUCOSE FOR RELIEVING PAIN FOLLOWING INTRAMUSCULAR INJECTION IN TERM NEONATES F. Sajedi 1*, Z. Kashaninia, M. Rahgozar 3 and L. Radrazm 4 1) Department of Clinical Sciences, University
More informationEffi cacy of sweet solutions for analgesia in infants between 1 and 12 months of age: a systematic review
An appendix is published online only. To view this fi le please visit the journal online (http://adc.bmj.com) 1 The Hospital for Sick Children, Toronto, Canada 2 Lawrence S. Bloomberg Faculty of Nursing,
More informationORAL GLUCOSE SOLUTION BEFORE VENEPUNCTURE FOR NEONATAL PAIN RELIEF
ORAL GLUCOSE SOLUTION BEFORE VENEPUNCTURE FOR NEONATAL PAIN RELIEF DR I Wayan Retayasa Department of Child Health Wangaya General Hospital Medical Faculty Udayana University Denpasar Bali Indonesia Training
More informationSEDATION FOR SMALL PROCEDURES
SEDATION FOR SMALL PROCEDURES Sinno Simons Erasmus MC Sophia Children s Hospital Rotterdam, the Netherlands s.simons@erasmusmc.nl SEDATION in newborns How and when How to evaluate How to dose Why to use
More informationNeonatal Stress, Pain and Cognitive. Anne Synnes MDCM, MHSc BC Women s Hospital University of British Columbia
Neonatal Stress, Pain and Cognitive Deficits Anne Synnes MDCM, MHSc BC Women s Hospital University of British Columbia Learning objectives Scope of pain and stress in the preterm baby in the NICU Effect
More informationExpressed Breast Milk vs 25% Dextrose in Procedural Pain in Neonates: A Double Blind Randomized Controlled Trial
R E S E A R C H P A P E R Expressed Breast Milk vs 25% Dextrose in Procedural Pain in Neonates: A Double Blind Randomized Controlled Trial JAGDISH PRASAD SAHOO, SUMAN RAO, SAUDAMINI NESARGI, THOMAS RANJIT,
More informationPain Control in the NICU
Pain Control in the NICU By Robert Cicco, MD Introduction There is ample documentation in the literature that newborn infants experience pain and exhibit a variety of both physiologic and behavioral responses
More informationOutcomes of Infants with Neonatal Abstinence Syndrome
Outcomes of Infants with Neonatal Abstinence Syndrome Caroline O. Chua, MD, FAAP Medical Director, Division of Neonatology Director, Neonatal Follow Up Clinic Nemours Children s Hospital Orlando, Florida
More informationProgress in the Control of Childhood Obesity
William H. Dietz, MD, PhD a, Christina D. Economos, PhD b Two recent reports from the Centers for Disease Control and Prevention and reports from a number of states and municipalities suggest that we are
More informationPain Management in the NICU. Tamorah Lewis MD, PhD
Pain Management in the NICU & Iatrogenic Opiate Withdrawal Tamorah Lewis MD, PhD Assistant Professor Divisions of Neonatology & Clinical Pharmacology, Toxicology and Therapeutic Innovation The Children's
More informationAMERICAN ACADEMY OF PEDIATRICS
AMERICAN ACADEMY OF PEDIATRICS The Role of the Primary Care Pediatrician in the Management of High-risk Newborn Infants ABSTRACT. Quality care for high-risk newborns can best be provided by coordinating
More informationSucrose Use in Children: A Systematic Review
Walden University ScholarWorks Walden Dissertations and Doctoral Studies Walden Dissertations and Doctoral Studies Collection 2017 Sucrose Use in Children: A Systematic Review Dorothy Luongo Walden University
More informationipad Increasing Nickel Exposure in Children
ipad Increasing Nickel Exposure in Children abstract We discuss allergic contact dermatitis to the ipad to highlight a potential source of nickel exposure in children. Pediatrics 2014;134:e580 e582 AUTHORS:
More informationLearning Objectives. At the conclusion of this module, participants should be better able to:
Learning Objectives At the conclusion of this module, participants should be better able to: Treat asymptomatic neonatal hypoglycemia with buccal dextrose gel Develop patient-specific approaches to intravenous
More informationPain management in the neonate. Murila FV Martha Gatumbu
Pain management in the neonate Murila FV Martha Gatumbu Objectives 1. Neonatal sensory pain system 2. Neonatal pain assessment tools 3. Neuroprotective strategy for prems: Minimizing pain and stress Neuroprotective
More informationMinimal Enteral Nutrition
Abstract Minimal Enteral Nutrition Although parenteral nutrition has been used widely in the management of sick very low birth weight infants, a smooth transition to the enteral route is most desirable.
More informationAcute Pain NETP: SEPTEMBER 2013 COHORT
Acute Pain NETP: SEPTEMBER 2013 COHORT Pain & Suffering an unpleasant sensory & emotional experience associated with actual or potential tissue damage, or described in terms of such damage International
More informationLearning Objectives. What are children most afraid of when coming to see a doctor?
Don t have enough staff for Pain Control? Funny, how there is always enough to restrain a child Stefan J. Friedrichsdorf, MD, FAAP Medical Director, Department of Pain Medicine, Palliative Care & Integrative
More informationNeonatal Pain Management: Integrating the science, evidence, and art of therapeutics with early development
Disclosures: Dr. Anand has no financial relationships with any commercial, pharmaceutical, or medical device companies related to this presentation; there are no conflicts of interest to disclose. As senior
More informationAge Limit of Pediatrics
POLICY STATEMENT Organizational Principles to Guide and Define the Child Health Care System and/or Improve the Health of all Children Age Limit of Pediatrics Amy Peykoff Hardin, MD, FAAP, a Jesse M. Hackell,
More informationRelationships Relationships
PRENATAL OPIATE EXPOSURE IMPACT ON EARLY CHILDHOOD LEARNING AND BEHAVIOR Ira J. Chasnoff, MD NTI Upstream www.ntiupstream.com Children grow and develop in the context of Attachment: Basic Concept Attachment:
More informationARTICLE SUMMARIES MAY Receive summaries of articles in each month s issue of Pediatrics when you sign up at
ARTICLE SUMMARIES MAY 2015 Receive summaries of articles in each month s issue of Pediatrics when you sign up at www.pediatrics.org. First Use of a Serogroup B Meningococcal Vaccine in the US in Response
More informationMarijuana During Pregnancy: An Overview
Marijuana During Pregnancy: An Overview Marijuana: Epidemiology Marijuana is the most commonly used illicit drug and, after alcohol and tobacco, the most commonly used drug during pregnancy (1) 48-60%
More informationNeurobiology of Acute Pain in Early Life
Neurobiology of Acute Pain in Early Life K. J. S. Anand, MBBS, D.Phil., FAAP, FCCM, FRCPCH Morris & Hettie Oakley Endowed Chair of Critical Care Medicine Professor of Pediatrics, Anesthesiology, Pharmacology
More informationNIH Public Access Author Manuscript Nat Neurosci. Author manuscript; available in PMC 2006 September 5.
NIH Public Access Author Manuscript Published in final edited form as: Nat Neurosci. 2006 August ; 9(8): 1004 1006. Maternal presence serves as a switch between learning fear and attraction in infancy
More informationObjectives. Terminology 6/29/2016. Neuroprotective Care in the NICU
Neuroprotective Care in the NICU Small Baby Unit July 2016 Mary Wardell PT, DPT, PCS Objectives Review NICU neuroprotective core measures Discuss sensory processing, what it is, and how it typically develops
More informationThe Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome
Neonatal Nursing Education Brief: The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome https://www.seattlechildrens.org/healthcareprofessionals/education/continuing-medical-nursing-education/neonatalnursing-education-briefs/
More informationInfant pain management: a developmental neurobiological approach
Infant pain management: a developmental neurobiological approach Maria Fitzgerald* and Suellen M Walker review Summary Infant pain is a clinical reality. Effective pain management in infants requires a
More informationPAIN IS A SUBJECTIVE EXPERIENCE: It is not a stimulus. MAJOR FEATURES OF THE PAIN EXPERIENCE: Sensory discriminative Affective (emotional) Cognitive
PAIN PAIN IS A SUBJECTIVE EXPERIENCE: It is not a stimulus MAJOR FEATURES OF THE PAIN EXPERIENCE: Sensory discriminative Affective (emotional) Cognitive MEASUREMENT OF PAIN: A BIG PROBLEM Worst pain ever
More informationEffects of Prenatal Illicit Drug. Use on Infant and Child
Effects of Prenatal Illicit Drug Use on Infant and Child Development Andrew Hsi, MD, MPH Larry Leeman, MD, MPH Family Medicine MCH Grand Rounds 6 July 2011 Objectives for Presentation At the end of this
More informationJMSCR Vol 05 Issue 07 Page July 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i7.66 To Find the Order of BCG and Hepatitis
More informationSan Francisco Chronicle, June 2001
PAIN San Francisco Chronicle, June 2001 CONGENITAL INSENSITIVITY TO PAIN PAIN IS A SUBJECTIVE EXPERIENCE: It is not a stimulus MAJOR FEATURES OF THE PAIN EXPERIENCE: Sensory discriminative Affective (emotional)
More informationEvidence-Based Update: Using Glucose Gel to Treat Neonatal Hypoglycemia
Neonatal Nursing Education Brief: Evidence-Based Update: Using Glucose Gel to Treat Neonatal Hypoglycemia http://www.seattlechildrens.org/healthcare-professionals/education/continuing-medicalnursing-education/neonatal-nursing-education-briefs/
More information7/11/2018. Oral Dextrose Gel Treatment for Newborns with Hypoglycemia Reduces NICU Admissions DISCLOSURE. Objectives
Gaps in Knowledge, Competence, Performance, or Patient Outcomes DISCLOSURE The content of this presentation does not relate to any product of a commercial entity; therefore, I have no relationships to
More informationService Line: Rapid Response Service Version: 1.0 Publication Date: July 04, 2018 Report Length: 47 Pages
CADTH RAPID RESPONSE REPORT: SUMMARY WITH CRITICAL APPRAISAL Oral Glucose Gel for Neonatal Hypoglycemia: A Review of Clinical Effectiveness, Cost- Effectiveness and Guidelines Service Line: Rapid Response
More informationNeonatal Outcomes in the Era of Periviability The Journey of Ontario s Tiniest Babies
Neonatal Outcomes in the Era of Periviability The Journey of Ontario s Tiniest Babies Paige Terrien, MD Director, Neonatal Follow Up Program University of Toronto Disclosure I do not have an affiliation
More informationReceptors and Neurotransmitters: It Sounds Greek to Me. Agenda. What We Know About Pain 9/7/2012
Receptors and Neurotransmitters: It Sounds Greek to Me Cathy Carlson, PhD, RN Northern Illinois University Agenda We will be going through this lecture on basic pain physiology using analogies, mnemonics,
More informationVirtually everyone has experienced pain in one
Transfer of Advances in Sciences into Dental Education Recent Insights into Brainstem Mechanisms Underlying Craniofacial Pain Barry J. Sessle, B.D.S., M.D.S., B.Sc., Ph.D., F.R.S.C., D.Sc. (honorary) Abstract:
More informationPAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1)
Pain - subjective experience associated with detection of tissue damage ( nociception ) acute - serves as a warning chronic - nociception gone bad often accompanied by clinical depression fibromyalgia,
More informationA study of pain management practices during the prolonged hospitalisation of infants.
A study of pain management practices during the prolonged hospitalisation of infants. Denise Margaret Harrison A research thesis submitted in total fulfilment of the requirements of Doctor of Philosophy
More informationWhile the target users of this CPG will likely be physicians and nurses, pain management is the responsibility of all health care professionals.
1.0 Introduction The purpose of this Clinical Practice Guideline (CPG) is to optimize the assessment and management of pain in children at SickKids with the goal of limiting or preventing pain. The document
More informationNEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE
NEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE Salma Ali MD, Debra Brendel RN, BSN, MSN and Ona Fofah MD Division of Neonatology and Newborn Medicine Department of
More informationPain Pathways. Dr Sameer Gupta Consultant in Anaesthesia and Pain Management, NGH
Pain Pathways Dr Sameer Gupta Consultant in Anaesthesia and Pain Management, NGH Objective To give you a simplistic and basic concepts of pain pathways to help understand the complex issue of pain Pain
More informationAnesthetic-Induced Neuronal Brain Injury in Infants: Finding an Answer with Clinical Studies
Anesthetic-Induced Neuronal Brain Injury in Infants: Finding an Answer with Clinical Studies Andrew Davidson Royal Children s Hospital Melbourne AUSTRALIA Local anesthesia infiltration by the surgeon has
More informationSummary of Changes: References/content updated to reflect most current standards of practice.
Alaska Native Medical Center: Mother Baby Unit Guideline: Neonatal Hypoglycemia Subject: Neonatal Hypoglycemia REVISION DATE: Jan 2015,12/2011, 02/2009, 11, 2007, 07/2007,04/2001, 04/1999 REPLACES: NSY:
More informationGestational age (w eeks) Perception
Gestational age (w eeks) 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 Perception Cuteneous sensory perception MY EL INISATION Nerve tracts in the Spinal Cord and Brain Stem Internal Capsula
More informationAdvancing the Care of Pregnant and Parenting Women with Opioid Use Disorder and their Infants: A Foundation for Clinical Guidance
Advancing the Care of Pregnant and Parenting Women with Opioid Use Disorder and their Infants: A Foundation for Clinical Guidance Karol Kaltenbach, PhD Emeritus Professor of Pediatrics Sidney Kimmel Medical
More informationHazards and Benefits of Postnatal Steroids. David J. Burchfield, MD Professor and Chief, Neonatology University of Florida
Hazards and Benefits of Postnatal Steroids David J. Burchfield, MD Professor and Chief, Neonatology University of Florida Disclosures I have no financial affiliations or relationships to disclose. I will
More informationUnderstanding Confounding in Research Kantahyanee W. Murray and Anne Duggan. DOI: /pir
Understanding Confounding in Research Kantahyanee W. Murray and Anne Duggan Pediatr. Rev. 2010;31;124-126 DOI: 10.1542/pir.31-3-124 The online version of this article, along with updated information and
More informationNeonatal abstinence syndrome
PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on the Neonatal Abstinence Syndrome. These podcasts are designed to give medical students an overview of key topics in pediatrics.
More informationSpecialist neonatal respiratory care for babies born preterm
National Institute for Health and Care Excellence Draft for Consultation Specialist neonatal respiratory care for babies born preterm [E] Evidence reviews for sedation and analgesia NICE guideline
More informationHow Well Do Clinical Pain Assessment Tools Reflect Pain in Infants?
Página 1 de 12 RESEARCH ARTICLE How Well Do Clinical Pain Assessment Tools Reflect Pain in Infants? Article Related Content Comments: 0 Rebeccah Slater 1*, Anne Cantarella 2, Linda Franck 3, Judith Meek
More informationCOMMITTEE ON NUTRITION
COMMITTEE ON NUTRITION CHILDHOOD DIET AND CORONARY HEART DISEASE A SUBCOMMITTEE of the Inter-Society Commission for Heart Disease Resources recently recommended an immediate, nationwide change in dietary
More informationOverview of Pain Types and Prevalence
Pain Resource Nurse Overview of Pain Types and Prevalence Pain Resource Nurse Program Module 1 The Resource Center of the Alliance of State Pain Initiatives University of Wisconsin Board of Regents, 2011
More informationDaniel S. Sitar, BScPharm, PhD, FCP Professor Emeritus University of Manitoba Editor: Journal of Clinical Pharmacology
March 8, 2011 Daniel S. Sitar, BScPharm, PhD, FCP Email: sitar@cc.umanitoba.ca Professor Emeritus University of Manitoba Editor: Journal of Clinical Pharmacology DEFINITIONS Pain: The unpleasant sensory
More informationOptimal Distribution and Utilization of Donated Human Breast Milk: A Novel Approach
653738JHLXXX10.1177/0890334416653738Journal of Human LactationSimpson et al research-article2016 Original Research: Brief Report Optimal Distribution and Utilization of Donated Human Breast Milk: A Novel
More informationThe Flavor World of Childhood: Basic Biology and Health Implications. Julie A. Mennella, PhD Monell Chemical Senses Center Philadelphia, PA
The Flavor World of Childhood: Basic Biology and Health Implications Julie A. Mennella, PhD Monell Chemical Senses Center Philadelphia, PA Julie A. Mennella, PhD Financial Disclosures No relevant financial
More informationMAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids
MAT IN PREGNANCY R. COREY WALLER MD, MS PRINCIPAL, HEALTH MANAGEMENT ASSOCIATES FACULTY, INSTITUTE FOR HEALTHCARE INNOVATION (IHI) CHAIR, LEGISLATIVE ADVOCACY COMMITTEE, ASAM KAYLA LIFE STAGE 1: ADOLESCENCE
More informationMetabolic Programming. Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD
Metabolic Programming Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD nutritional stress/stimuli organogenesis of target tissues early period critical window consequence of stress/stimuli are
More informationThe Pennsylvania State University. The Graduate School. College of Health and Human Development
The Pennsylvania State University The Graduate School College of Health and Human Development A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED TRIAL EXAMINING THE ANALGESIC PROPERTIES OF ORAL SUCROSE DURING
More informationPATENT DUCTUS ARTERIOSUS IN THE PRETERM INFANT EVIDENCE FOR & AGAINST TREATMENT
PATENT DUCTUS ARTERIOSUS IN THE PRETERM INFANT EVIDENCE FOR & AGAINST TREATMENT Dr. Youssef Abou Zanouna, FRCPI, FACC Consultant Pediatric Cardiologist King Fahd Military Medical Complex Dhahran Introduction
More informationPRACTICE GUIDELINES WOMEN S HEALTH PROGRAM
C Title: NEWBORN: HYPOGLYCEMIA IN NEONATES BORN AT 35+0 WEEKS GESTATION AND GREATER: DIAGNOSIS AND MANAGEMENT IN THE FIRST 72 HOURS Authorization Section Head, Neonatology, Program Director, Women s Health
More informationOffice of Evidence Based Practice Specific Care Question: Frenulectomy
Specific Care Question : Is frenulectomy beneficial in infants with ankyloglossia? Question Originator: Steven Olsen, MD Associate Division Director, Neonatology Plain Language Summary from The Office
More informationManagement of Suspected Opioid Overdose With Naloxone by EMS Personnel
Management of Suspected Opioid Overdose With Naloxone by EMS Personnel DATE: January 10, 2018 PRESENTED BY: Roger Chou, M. D., Director, Pacific Northwest Evidence - based Practice Center Purpose of Report
More informationP ain management of neonates admitted to neonatal
F46 ORIGINAL ARTICLE Morphine in ventilated neonates: its effects on arterial blood pressure S H P Simons, D W E Roofthooft, M van Dijk, R A van Lingen, H J Duivenvoorden, J N van den Anker, D Tibboel...
More informationInfection. Risk factor for infection ACoRN alerting sign with * Clinical deterioration. Problem List. Respiratory. Cardiovascular
The ACoRN Process Baby at risk Unwell Risk factors Post-resuscitation requiring stabilization Resuscitation Ineffective breathing Heart rate < 100 bpm Central cyanosis Support Infection Risk factor for
More informationPain & Sedation Management in PICU. Marut Chantra, M.D.
Pain & Sedation Management in PICU Marut Chantra, M.D. Pain Diseases Trauma Procedures Rogers Textbook of Pediatric Intensive Care, 5 th ed, 2015 Emotional Distress Separation from parents Unfamiliar
More informationOf the following, the BEST nutritional strategy for this infant would be to add:
NeoReviewsPlus 2009 August 09 Assessment Your Score Page 1234 5678910 My Learning Plan 1 2 3 January 09 February 09 March 09 A 700-g infant regained her birthweight 14 days after birth. She is receiving
More informationPain, opioid tolerance and sensitisation to nociception in the neonate
Best Practice & Research Clinical Anaesthesiology Vol. 18, No. 2, pp. 291 302, 2004 doi:10.1016/j.bpa.2003.12.008 available online at http://www.sciencedirect.com 6 Pain, opioid tolerance and sensitisation
More informationNeonatal Hypoglycemia. Presented By : Kamlah Olaimat 25\7\2010
Neonatal Hypoglycemia Presented By : Kamlah Olaimat 25\7\2010 Definition The S.T.A.B.L.E. Program defines hypoglycemia as: Glucose delivery or availability is inadequate to meet glucose demand (Karlsen,
More informationNewborn Glucose Management Clinical Decision Support System
Newborn Glucose Management Clinical Decision Support System Marie Kozel, MBA, BSN, RNC-BC 6 th Annual Nursing Quality Conference 2012 Thursday, January 26, 2012 2:45 PM Objectives 1. Describe a newborn
More informationPAIN MANAGEMENT IN CHILDREN
SIOP PODC Supportive Care Education (ICON 2016) Presentation Date: 23 rd January 2016 PAIN MANAGEMENT IN CHILDREN Aziza Shad, MD Ellen Wasserman Chair of Pediatrics Chief, Division of Pediatric Hematology
More informationClinical Management of Neonatal Abstinence Syndrome. Tricia L. Romesberg, DNP, MSN, ARNP, CNNP
Clinical Management of Neonatal Abstinence Syndrome Tricia L. Romesberg, DNP, MSN, ARNP, CNNP Timeline Incidence of NAS Healthcare Cost and Utilization Project (HCUP), 1999-2013 State Inpatient Databases
More informationOpioid Induced Hyperalgesia (OIH)
Opioid Induced Hyperalgesia (OIH) How to Receive Your CE Credits Read your selected course Completed the quiz at the end of the course with a 70% or greater. Complete the evaluation for your selected course.
More informationPrevention and Management of Procedural Pain in the Neonate: An Update COMMITTEE ON FETUS AND NEWBORN and SECTION ON ANESTHESIOLOGY AND PAIN MEDICINE
POLICY STATEMENT Organizational Principles to Guide and Define the Child Health Care System and/or Improve the Health of all Children Prevention and Management of Procedural Pain in the Neonate: An Update
More informationOpioid use in pregnancy and Neonatal Abstinence Syndrome
Opioid use in pregnancy and Neonatal Abstinence Syndrome Morissa Ladinsky, MD Assoc. Professor of Pediatrics Division of General Pediatrics and Adolescent Medicine UAB Objectives 1. Understand the magnitude,
More informationNeonatal Abstinence: The epidemic Its Impact on All of Us
Neonatal Abstinence: The epidemic Its Impact on All of Us Michelle Bode MD, MPH Neonatologist Crouse Hospital Assistant Professor Pediatrics SUNY Upstate Objectives & Disclosure Statement 1) The participant
More informationFeeding the Small for Gestational Age Infant. Feeding the Small for Gestational Age Infant
Feeding the Small for Gestational Age Infant Feeding the Small for Gestational Age Infant What s the right strategy? Infants born small-for-gestational age (SGA) are at higher risk for adult diseases.
More informationResidency Training in Transition of Youth With Childhood-Onset Chronic Disease Manisha S. Patel and Kitty O'Hare. DOI: /peds.
Residency Training in Transition of Youth With Childhood-Onset Chronic Disease Manisha S. Patel and Kitty O'Hare Pediatrics 2010;126;S190 DOI: 10.1542/peds.2010-1466P Updated Information & Services References
More informationResults. NeuRA Motor dysfunction April 2016
Introduction Subtle deviations in various developmental trajectories during childhood and adolescence may foreshadow the later development of schizophrenia. Studies exploring these deviations (antecedents)
More informationCLOSING OF THE ANTERIOR FONTANELLE
CLOSING OF THE ANTERIOR FONTANELLE By MILTON R. AISEN50N, M.D. Flushing, N.Y. C URRENT pediatric textbooks differ in statements about the age at which the antenor fontanelle closes normally. Brenneman
More informationSpecial Issue on Pain and Itch
Special Issue on Pain and Itch Title: Recent Progress in Understanding the Mechanisms of Pain and Itch Guest Editor of the Special Issue: Ru-Rong Ji, PhD Chronic pain is a major health problem world-wide.
More information(1996) 2002 JAMA. IDM
Neonatal Sedation Joseph Cravero MD First Question Does Pain/Stress Control Matter? Especially in very young patients. Really? Responses to Pain - Newborns learn quickly Taddio et. al. 2002 JAMA. IDM s
More informationPOLICY and PROCEDURE
Misericordia Community Hospital Administration of Intravenous FentaNYL During Labour POLICY and PROCEDURE Labour and Delivery Manual Original Date Revised Date Approved by: Director, Women s Health, Covenant
More informationSonoma Valley Hospital Sonoma Valley Healthcare District Policy and Procedure Organizational. Page: 1
Title: PAIN MANAGEMENT Sonoma Valley Hospital Organizational Number: PC-104 Page: 1 Effective Date: 3/96 Mary Kelly, R.N., M.P.A. 12/07 Approved By Date Revision Dates: 07/01, 02/02 Signature on file Signature
More informationProf Wayne Derman MBChB,BSc (Med)(Hons) PhD, FFIMS. Pain Management in the Elite Athlete: The 2017 IOC Consensus Statement
Prof Wayne Derman MBChB,BSc (Med)(Hons) PhD, FFIMS Pain Management in the Elite Athlete: The 2017 IOC Consensus Statement 2 as 20 Experts published and leaders in their respective field 12 month lead in
More informationBiomedical music therapy as procedural support: Understanding the effects of music therapy on pain and anxiety from a neurological perspective
Biomedical music therapy as procedural support: Understanding the effects of music therapy on pain and anxiety from a neurological perspective Olivia Swedberg Yinger, MME, MT-BC The Florida State University
More informationPreterm infants are exposed to multiple stressors such as
ORIGINAL ARTICLE Body Movements: An Important Additional Factor in Discriminating Pain From Stress in Preterm Infants Liisa Holsti, PhD,* Ruth E. Grunau, PhD,* Tim F. Oberlander, MD,* Michael F. Whitfield,
More informationProceedings of the World Small Animal Veterinary Association Sydney, Australia 2007
Proceedings of the World Small Animal Sydney, Australia 2007 Hosted by: Next WSAVA Congress REDUCING THE PAIN FACTOR AN UPDATE ON PERI-OPERATIVE ANALGESIA Sandra Forysth, BVSc DipACVA Institute of Veterinary,
More informationDISCLOSURES. Learning goals 19/09/2013 PEDIATRIC ACUTE PAIN MANAGEMENT. No financial investment in the material or medications presented
PEDIATRIC ACUTE PAIN MANAGEMENT Dr. Samina Ali, MDCM, FRCPC(PEM) Associate Professor Departments of Pediatrics & Emergency Medicine University of Alberta September 2013 DISCLOSURES No financial investment
More informationNutritional factors affecting serum phenylalanine concentration during pregnancy for identical twin mothers with phenylketonuria
Nutritional factors affecting serum phenylalanine concentration during pregnancy for identical twin mothers with phenylketonuria By: C. Fox, J. Marquis, D.E. Kipp This is the accepted version of the following
More informationEmergent Issues Affecting Early Intervention/ Early Childhood. Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC
Emergent Issues Affecting Early Intervention/ Early Childhood Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC Conversation Points Changing Demographics Emergent Trends
More informationMaternal and Infant Nutrition Briefs
Maternal and Infant Nutrition Briefs A research-based newsletter prepared by the University of California for professionals interested in maternal and infant nutrition March/April 2003 New Guidelines on
More informationThe Methadone Awareness Test*
The Methadone Awareness Test*!" #!$# # #%!&# %# #!! *The Methadone Awareness Test has been updated from the website. ' (!) %##% #! '! * ##" # ##! ' %#% %!% %#+%#%!,% %# #!, %%# %!'%%#%, %## % #!,% %!'
More informationPostnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.
Complete Summary GUIDELINE TITLE Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. BIBLIOGRAPHIC SOURCE(S) Postnatal corticosteroids to treat or prevent chronic lung
More information